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Skin irritation potential of graphene-based
materials using a non-animal test†
Laura Fusco, a Marina Garrido, a Cristina Martín, b,c Silvio Sosa, d
Cristina Ponti, d Alba Centeno, e Beatriz Alonso, e Amaia Zurutuza, e
Ester Vázquez, b,c Aurelia Tubaro, d Maurizio Prato a,f,g and Marco Pelin *d
Besides inhalation, skin contact may be considered one of the most relevant exposure routes to gra-
phene-based materials (GBMs). However, very few data on the cutaneous toxicity of these materials are
available, so far. This study is focused on skin irritation potential of a panel of GBMs: few-layer graphene
(FLG), exfoliated by ball milling of graphite, FLG exfoliated by ultrasonication using sodium dodecyl
sulfate (FLG-SDS) or sodium dodecylbenzenesulfonate (FLG-SDBS), CVD-graphene, obtained by chemical
vapor deposition, graphene oxide (GO) and reduced GO (rGO). Skin irritation was assessed using the
SkinEthic™ Reconstructed human Epidermis (RhE), following the Organisation for Economic Co-oper-
ation and Development (OECD) Test Guideline (TG) 439. Even though not validated for nanomaterials, the
OCED TG 439 turned out to be applicable also for GBM testing, since no interference with the methyl-
thiazolyldiphenyl-tetrazolium bromide (MTT) reduction, used as a ﬁnal readout, was found. Furthermore,
direct epidermal exposure to powdered GBMs mimics the actual human exposure, avoiding interference
by the cell culture medium (protein corona formation). Only GBMs prepared with irritant surfactants
(FLG-SDS and FLG-SDBS), but not the others, reduced RhE viability at levels lower than those predicting
skin irritation (≤50%), suggesting irritant properties. This result was further conﬁrmed by measuring cyto-
kine (IL-1α, IL-6 and IL-8) release by GBM-treated RhE and by histological analysis as additional readouts
to implement the guideline. On the whole, these results demonstrate that GBMs prepared with non-irri-
tant exfoliation agents do not induce skin irritation after a single acute exposure.
Introduction
Skin represents the major barrier between the human body
and environment. Its anatomical structure guarantees protec-
tion against external factors, including physical, chemical, and
biological agents. An emerging area of concern is represented
by skin exposure to manufactured nanomaterials, including
metal nanoparticles (i.e. TiO2NPs, AgNPs, AuNPs, etc.), nano-
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†Electronic supplementary information (ESI) available: Supplementary Fig. S1.
Characterization of disks of CVD-graphene monolayers by optical microscopy (A)
and Raman spectroscopy (B). Supplementary Fig. S2. Assessment of technical pro-
ficiency on RhE, testing the ten Proficiency substances (PS) according to the
OECD TG 431. The table reports the % of RhE viability after PS exposure following
the SkinEthic™ Skin Irritation Test-42bis and are the mean ± SE of three indepen-
dent experiments. Irritancy classification was defined on the basis of the
threshold given by the OCED TG 439. Supplementary Fig. S3. TGA analyses for the
starting graphite, FLG, FLG-SDS and FLG-SDBS (A) and for GO and rGO materials
(B). Supplementary Fig. S4. HRTEM picture of FLG. Supplementary Fig. S5. Total
reflection X-Ray fluorescence (TXRF) of FLG. Supplementary Fig. S6. XRD analysis
of GO (A) and rGO (B). Supplementary Fig. S7. Representative TEM images of GO
(A) and rGO (B). Supplementary Fig. S8. MTT interference with GBMs-exposed
RhE media. RhE tissues were exposed to GBMs for 42 minutes followed by
42 hours post-incubation without the materials. After treatment, RhE media were
collected and 100 µL of each was exposed to 10 µL of MTT reagent (5 mg mL−1)
for 3 hours at 37 °C and the absorbance read at 570 nm. As a comparison, 100 µL
of the same RhE media were exposed to 10 µL of the WST-8 reagent for 3 hours at
37 °C and the absorbance read at 450 nm. Results are the mean ± SE of three inde-
pendent experiments. See DOI: 10.1039/c9nr06815e
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structured hydrogels and polymers or carbon-based nano-
materials (i.e. carbon nanotubes, fullerenes, carbon-quantum
dots, etc.). Graphene-based materials (GBMs) represent one of
the last discovered members of carbon-based nanomaterials.1
GBMs, including few-layer graphene (FLG), its oxidative
product graphene oxide (GO) and other functionalized gra-
phene materials, have been surrounded by increasing interest
and expectations due to their unique physicochemical pro-
perties. Indeed, on the basis of their high surface area, extra-
ordinary electrical and thermal conductivity and strong
mechanical strength, GBMs are promising nanotools for a
wide range of possible applications in the fields of nanoelec-
tronics and energy technology, biosensoristic field and bio-
medicine.2 Given these properties, an active field of research is
represented by the investigation of GBM applications at the
skin level, mainly as artificial and electronic skin, wound
healing dressings and skin sensors.3,4 Considering these
promising applications, the cutaneous exposure route to GBMs
can be assumed as one of the most important ones in the
actual scenario. However, the major risk for human health
posed by GBMs is currently related to their occupational
exposure rather than to an extensive exposure by consumers.5
Actually, during GBM industrial or laboratory scale production,
skin may be considered as one of the main involved exposure
routes, after inhalation.6,7 Moreover, it has to be considered
that around 90% of skin diseases related to the occupational
settings are represented by irritant and allergic contact
dermatitis.8
However, despite the importance of skin exposure and the
dermotoxic potential of GBMs, very limited data on the
cutaneous toxicity of these materials are currently available.
Only few in vitro data regarding the eﬀects on skin fibroblasts9
and keratinocytes10–13 are available, so far. In HaCaT skin kerati-
nocytes, we previously demonstrated that FLG and GO reduced
cell viability after interaction with plasma membrane.11 The
eﬀect was significant after exposure times as long as 72 hours at
concentrations higher than 1–10 µg mL−1, involving a reactive
oxygen species (ROS)-dependent mitochondrial dysfunction,
driven by the activation of flavon-based oxidative enzymes.12
Hence, considering the potential toxicity of GBMs at
the cutaneous level, this study investigates skin irritation pro-
perties of a panel of diﬀerent materials, including FLG,
obtained by diﬀerent procedures, disks of CVD-graphene
monolayers, obtained by chemical vapor deposition, GO and
its chemically reduced form rGO. Since no specific guidelines
for skin testing of nanomaterials are currently available, a
specific guideline given by the Organisation for Economic
Co-operation and Development (OECD) for in vitro testing of
chemicals at the skin level was followed. As a first step,
the feasibility to apply the OECD guideline to test also a
particular class of nanomaterials, such as GBMs, was
evaluated. In addition, to implement the OECD guideline
procedure for skin irritation, epidermal samples exposed to
GBMs were subjected also to histological analysis and the
release of selected pro-inflammatory cytokines was also
determined.
Experimental
Materials and reagents
FLG was obtained by ball-milling under solvent-free con-
ditions, as a powder easily dispersible in culture media.14–16
FLG-SDS and FLG-SDBS were prepared by ultrasonication
using sodium dodecyl sulfate (SDS) or sodium dodecylbenze-
nesulfonate (SDBS), respectively. GO (batch #GOB067) and rGO
(batch #rGOPB010) were kindly supplied by Graphenea (San
Sebastián, Spain).
Disks of CVD graphene monolayers were supplied by
Graphenea (San Sebastián, Spain). Graphene was grown by
Chemical Vapour Deposition (CVD) on a copper foil catalyst.
After growth, a sample of graphene grown on copper foil (5 ×
5 cm2 size) was spin-coated with 80 nm of 495 K PMMA (poly-
methyl methacrylate). The stack was laminated in a 50 µm
thick PMMA laminate at 150 °C using a pressure of 0.5 mbar.
After this, the copper was properly etched in a ferric cloride
(FeCl3) containing solution and cleaned several times with dis-
tilled water and HCl 10 wt% solution. Once the graphene film
was cleaned, the square laminate was cut in small disks of
6 mm2 for testing. Disks of CVD-graphene monolayers were
analyzed by optical microscopy using an Eclipse LV 100ND
microscope and Raman spectroscopy (WiTec Confocal Raman
Microscope) with a 532 nm laser wavelength (ESI Fig. S1†).
Graphite flakes (particle size = +100 mesh), sodium dodecyl
sulfate (SDS) and sodium dodecyl-benzenesulfonate (SDBS)
used to obtain FLG-SDS and FLG-SDBS were purchased from
Sigma-Aldrich (Milan, Italy) and were used without further
purification. For the preparation of FLG by ball-milling tech-
niques, SP-1 graphite powder was purchased from Bay Carbon,
Inc. (Bay City, MI, USA) and melamine from Sigma-Aldrich
(Madrid, Spain).
Preparation of FLG, FLG-SDS and FLG-SDBS
Exfoliation with melamine (FLG). A mixture of 7.5 mg of
graphite and 22.5 mg of melamine (1,3,5-triazine-2,4,6-tri-
amine) was ball-milled at 100 rpm for 30 minutes using a
Retsch PM 100 planetary mill under an air atmosphere. The
resulting solid mixture was dispersed in 20 mL of water and
sonicated for 1 min to produce a dark suspension. Melamine
was afterwards eliminated by dialysis. Some precipitate, con-
sisting of poorly exfoliated graphite, was removed from the
liquid fraction after stabilization for 5 days. The resulting FLG
water dispersions were lyophilized and the final graphene
powder was thoroughly characterized.17
Exfoliation with SDS (FLG-SDS). One gram of graphite was
added to 200 mL of SDS/Milli-Q water solution (0.05 mg mL−1).
Then, the dispersion was sonicated for 2 hours and sub-
sequently was centrifuged for 45 minutes at 500 rpm. Finally,
the supernatant was collected and lyophilized, aﬀording the
final FLG-SDS powder.
Exfoliation with SDBS (FLG-SDBS). One gram of graphite
was added to 200 mL of SDBS/Milli-Q water solution
(0.05 mg mL−1). Then, the dispersion was sonicated for
2 hours and subsequently was centrifuged for 45 minutes at
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500 rpm. Finally, the supernatant was collected and lyophi-
lized, aﬀording the final FLG-SDBS powder.
Characterization techniques
Raman spectra were recorded on a Renishaw inVia Raman
Microscope at room temperature using an exciting laser source
of 532 nm. Raman samples were measured in solid state under
ambient conditions. Transmission electron microscopy (TEM)
micrographs were obtained using a Philips EM208 TEM and
RADIUS 2.0 software (EMSIS GmbH, Muenster, Germany). The
samples were dispersed in Milli-Q water and dropped onto a
lacey carbon copper grid (300 mesh); the solvent was removed
at room temperature. High-Resolution Transmission Electron
Microscopy (HRTEM) was performed in a JEOL 2100.
Thermogravimetric analyses (TGA) were performed with a TGA
Q500 (TA Instruments) under a N2 atmosphere. The sample
was introduced inside a platinum crucible and equilibrated at
100 °C followed by a 10 °C min−1 ramp between 100 and
800 °C. Elemental analysis was performed with a LECO
CHNS-932 analyzer, completely burning the sample with four
doses of oxygen, and quantifying the released gases by
thermal conductivity. Total reflection X-Ray fluorescence
(TXRF) measurements of FLG and GO were performed using a
Bruker-S2 PicoFox TXRF spectrometer.
Skin irritation
SkinEthic™ Reconstructed Human Epidermis (RhE) model.
Skin irritation was evaluated on the SkinEthic™ Reconstructed
Human Epidermis (RhE), a fully diﬀerentiated three-dimen-
sional epidermal tissue constituted of normal human keratino-
cytes in a chemically defined medium grown at the air–liquid
interface. The SkinEthic™ RhE model was purchased from
Episkin (Lyon, France) and checked for quality control criteria
(mean optical density, O.D., of 3 negative controls = 1.37 ± 0.04
and mean viability of 3 positive controls, 5% SDS = 2.1 ±
0.4%), before being used for the experiments. Technical profi-
ciency was assessed testing the ten Proficiency substances
according to OECD TG 439 (ESI Fig. S2†).
SkinEthic™ Skin Irritation Test-42bis. Skin irritation induced
by GBMs was evaluated on the SkinEthic™ RhE model follow-
ing the skin Irritation Test-42bis, a test compliant with the
OECD Test Guideline (TG) No. 439 for testing of chemicals,
due to the lack of specific OECD guidelines for nanomaterials.
As reported by OECD TG 439, RhE tissues (0.5 cm2, at day
17) were topically exposed to 16 mg FLG, FLG-SDS, FLG-SDBS,
GO or rGO (32 mg cm−2) in triplicate for 42 min at room temp-
erature (RT), after adding 10 μL of distilled water on the RhE
surface. For CVD-graphene, each disk was added above the epi-
dermis surface. As negative (vehicle) and positive controls,
tissues were exposed to phosphate buﬀered saline (PBS) or 5%
w/v SDS, respectively. As an additional positive control, RhE
was exposed also to 5% w/v SDBS. RhE tissues were then
washed 25 times with 1 mL PBS and transferred in a 6-well
plate with 2 mL growth medium. After 42 h post-incubation at
37 °C, 5% CO2, tissue viability was assessed by the MTT
reduction assay: RhE samples were transferred in a 24-well
plate containing 300 μL of MTT solution (1 mg mL−1) and
incubated for 3 h at 37 °C, 5% CO2. Formazan crystals were
then extracted from the tissue adding isopropanol (1.5 mL per
well, for 2 h at RT). Tissue viability is reported as % of negative
controls (vehicle), measuring the O.D. of each isopropanol
extract in triplicate at 570 nm by using an Automated
Microplate Reader EL 311s (Bio-Tek Instruments; Winooski,
VT, USA). Results are the mean ± SE of three independent
experiments.
Evaluation of GBM-induced interference
Since GBMs have been reported to interact with the MTT
reagent, giving its possible unspecific reduction,9 as prelimi-
nary experiments, “killed” RhE tissues were used to evaluate
the non-specific reduction of MTT. As reported by OECD TG
439, “killed” RhE tissues were obtained by freezing treatment
at −80 °C for 48 h and further processed for GBM treatment
and MTT assay as reported above. Data are reported as optical
density (O.D.) measured at 570 nm and are the mean ± SE of 3
independent experiments.
To further exclude interference, tissue media (200 µL) were
collected from RhE after GBM treatment and further exposed
to the MTT reagent for 3 h at 37 °C, as reported above. To
confirm the results, 200 µL of tissue media were exposed for
3 h at 37 °C to 20 μL of 2-(2-methoxy-4-nitrophenyl)-3-(4-nitro-
phenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-8) that is
not reported to have any unspecific interaction with GBMs.9
Absorbance was subsequently read at 450 nm by using an
Automated Microplate Reader EL 311s (Bio-Tek Instruments;
Winooski, VT, USA). Data are reported as O.D. measured at
450 nm and are the mean ± SE of 3 independent experiments.
Histological analysis
Immediately after treatment (42 min exposure to GBMs and/or
positive controls followed by 42 h post-exposure), RhE speci-
mens were collected from each insert and fixed in 10% (v/v)
neutral buﬀered formaldehyde. RhE specimens were then de-
hydrated, embedded in paraﬃn and longitudinally sectioned to
avoid any passive transport of GBMs deposited on the epider-
mis surface over the diﬀerent layers. Sections were then stained
with hematoxylin/eosin and analyzed under the Axio Scope A1
optical microscope (Zeiss, Milan, Italy) and microphotographs
were collected through the Axiocam 503 color digital camera
(Zeiss, Milan, Italy) using the Zen2 software, with a 40× magnifi-
cation. Images were collected from 6 diﬀerent samples.
Cytokine quantitation
Immediately after treatment (42 min exposure to GBMs and/or
positive controls followed by 42 h post-exposure), culture
media were collected and stored at −80 °C. A panel of pro-
inflammatory cytokines (interleukin, IL, -1α, -6 and -8) was
evaluated by specific sandwich ELISAs from Diaclone (Tema
Ricerca, Milan, Italy), following the manufacturer’s instruc-
tions. Results are expressed as pg mL−1 of cytokines released
in the media and are the mean ± SE of three independent
experiments.
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Statistical analysis
For skin irritation (OECD TG 439), results are expressed as %
of tissue viability with respect to vehicle controls and are the
mean ± SE of three independent experiments. As a threshold
given by OECD TG 439, viability ≤50% defines an irritant
compound.
Statistical analysis was performed by a one-way ANOVA fol-
lowed by Bonferroni’s post test (GraphPad Prism version 6.00)
and statistical significance was considered for p < 0.05.
Results
Physico-chemical characterization of GBMs
FLG. FLG was characterized by Raman spectroscopy, TEM,
TGA, TXRF and elemental analysis. The TGA curve displayed a
weight loss of 6.4% at 600 °C, indicating the low quantity of
oxygen groups generated by the exfoliation process (ESI
Fig. S3†). Elemental analysis showed average values of 94.93 ±
0.28% C, 0.55 ± 0.02% H, 0.54 ± 0.02% N (Table 1). The oxygen
content, less than 3.7%, is compatible with the weight loss at
600 °C observed by TGA, and the traces of melamine resulted
in only 0.81%.
The average Raman spectrum of FLG (40 spectra) showed
the two most intense peaks of graphene, the G band and the
2D peak, which appear at around ∼1580 cm−1 and
∼2700 cm−1, respectively (Fig. 1A). The average I(2D)/I(G) ratio
is 0.45, proving the samples to be few-layer graphene, usually
assigned for I(2D)/I(G) < 1.18,19 In fact, only 4 layers were calcu-
lated for FLG.20 When graphene is aﬀected by defects, a peak
appears at around 1345 cm−1 (D band). In this case, the
average spectrum of FLG shows a I(D)/I(G) ratio about 0.37,
corroborating the low level of defects which are attributed to
the edges of the micrometer flakes.21
The lateral dimension of FLG was estimated by TEM ana-
lysis after the evaluation of at least 100 diﬀerent sheets. The
Table 1 Physicochemical properties of FLG, FLG-SDS, FLG-SDBS, GO and rGO
GBMs
Elemental Analysis ± SD (%)
TGA weight
lossa (%)
Lateral
dimension ± SD (nm)
Lateral dimension
distribution (nm)
No.
layersC H N S O
FLG 94.93 ± 0.28 0.55 ± 0.02 0.54 ± 0.02 0.32 ± 0.03 <3.7 6 171 ± 147b 50–600b 4
FLG-SDS 56.65 ± 0.07 2.31 ± 0.05 0.39 ± 0.12 4.06 ± 0.12 <36.6 22 917 ± 389b 360–2200b 5
FLG-SDBS 52.75 ± 0.19 2.70 ± 0.04 0.13 ± 0.02 3.54 ± 0.12 <40.9 23 1097 ± 568b 400–4500b 5
GO 59.40 ± 0.10 1.40 ± 0.10 0.07 ± 0.02 2.50 ± 0.10 <36.6 46 15 100 ± 400c 6000–30000c 6d
rGO 81.30 ± 0.20 0.82 ± 0.02 0.21 ± 0.01 nd <17.7 17 5500 ± 200c 3000–11000c 2d
a Values determined at 600 °C. b Values determined by TEM on at least 100 sheets. c D50 values determined by laser diﬀraction in the GO slurry
and rGO powder. dCalculated by XRD in GO dry film and rGO powder.
Fig. 1 Raman spectra (λexc = 532 nm) of FLG (A), FLG-SDS (B), FLG-SDBS (C), GO (D) and rGO (E).
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lateral size distribution was located mainly between 50 and
600 nm with an average lateral dimension of 171 ± 147 nm
(Fig. 2A). A representative TEM image of the obtained FLG is
shown in Fig. 2B. The number of layers was also corroborated
by HRTEM analysis (ESI Fig. S4†).
Finally, since a stainless-steel flask is used during the ball-
milling process, TXRF was performed to ensure the absence of
metals, especially Fe, in the FLG sample, revealing a Fe con-
centration of only 0.074 mg L−1 (ESI Fig. S5†).
FLG-SDS and FLG-SDBS. FLG-SDS and FLG-SDBS were
characterized by Raman spectroscopy, TEM, TGA and elemen-
tal analysis. Raman analyses were performed to corroborate
the successful exfoliation of graphite in the presence of both
surfactants (Fig. 1B and C). The Raman spectrum of graphitic
Fig. 2 Lateral dimension distribution from TEM images (A, C, and E) and representative TEM images (B, D, and F) of FLG (A and B), FLG-SDS (C and
D) and FLG-SDBS (E and F).
Paper Nanoscale
614 | Nanoscale, 2020, 12, 610–622 This journal is © The Royal Society of Chemistry 2020
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
N
ov
em
be
r 2
01
9.
 D
ow
nl
oa
de
d 
on
 2
/2
8/
20
20
 1
1:
06
:2
4 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
materials was characterized by three bands: D (∼1350 cm−1), G
(∼1580 cm−1) and 2D (∼2700 cm−1). The change of the inten-
sity and position of the 2D band allowed determining the
number of layers present after the exfoliation procedure. In
this particular case, 5 layers were calculated for both FLG-SDS
and FLG-SDBS.20 Moreover, the I(D)/I(G) ratio allows estimat-
ing the number of defects present in the materials, the value
of this ratio being 0.31 for the FLG obtained in the presence of
SDS and 0.33 in the presence of SDBS.
The lateral dimensions of both materials were estimated by
TEM analysis after the evaluation of 100 diﬀerent sheets for
each case. The lateral size distribution was located between
360 and 2200 nm with an average lateral dimension of 917 ±
389 nm for FLG-SDS (Fig. 2C) and between 400 and 4500 nm
with an average lateral dimension of 1097 ± 568 nm for
FLG-SDBS (Fig. 2E). Representative TEM images of the
obtained materials are shown in Fig. 2.
Thermogravimetric analyses (TGA) were performed to deter-
mine the quantity of the surfactant present in the exfoliated
materials after the lyophilization process (ESI Fig. S3†). As
observed in the curves, the starting graphite does not present a
significant weight loss (1%). Therefore, the weight loss
observed after the exfoliation was due to the presence of both
surfactants that interact with the material and allow its exfolia-
tion in water, as well as to the defects created in the graphene
flakes during the exfoliation process (TGA weight losses of
22% and 23% for FLG-SDS and FLG-SDBS, respectively, at
600 °C). These values are compatible with the quantity of the
surfactant calculated from elemental analysis (36.6 mg of SDS
and 38.5 mg of SDBS in 100 mg of the respective obtained
materials).
GO and rGO. GO and rGO were characterized by Raman
spectroscopy, TEM, TGA and elemental analysis. The average
Raman spectrum of GO showed the two characteristic D and G
bands, with their maxima located at ∼1350 and ∼1600 cm−1,
respectively (Fig. 1D). Elemental analysis showed average
values of 59.40 ± 0.10% C, 1.40 ± 0.10% H, and 0.07 ± 0.02% N
(Table 1). At 600 °C, TGA showed a weight loss of 46% (ESI
Fig. S3†). The lateral dimension was determined by laser diﬀr-
action in the GO slurry: the lateral size distribution was
located mainly between 6000 and 30 000 nm with an average
lateral dimension of 15 100 ± 400 nm. X-ray diﬀraction (XRD)
analysis performed on a GO dry film (ESI Fig. S6†) revealed 6
layers. Representative TEM images are shown in ESI Fig. S7.†
The average Raman spectrum of rGO showed the two
characteristic D and G bands, with their maxima located at
∼1350 and ∼1590 cm−1, respectively (Fig. 1E). Elemental ana-
lysis showed average values of 81.30 ± 0.20% C, 0.82 ± 0.02%
H, 0.21 ± 0.01% N (Table 1). At 600 °C, TGA showed a weight
loss of 17% (ESI Fig. S3†). The shift to lower frequencies of the
G band, the increase of the percentage of carbon in the elemen-
tal analysis and the decrease of the weight loss in the TGA con-
firmed the successful reduction process. The lateral dimension
was determined by laser diﬀraction in rGO powder: the lateral
size distribution was located mainly between 3000 and
11 000 nm with an average lateral dimension of 5500 ± 200 nm.
XRD analysis performed on rGO powder (ESI Fig. S6†) revealed
2 layers. Representative TEM images are shown in ESI Fig. S7.†
SkinEthic™ Skin Irritation Test-42bis
To evaluate the irritation potential of GBMs, a set of experi-
ments was carried out following OECD TG 439, using the
SkinEthic™ Skin Irritation Test-42bis (42 minutes exposure +
42 hours post-incubation). Briefly, RhE tissues were topically
exposed to 16 mg of FLG, FLG-SDS, FLG-SDBS, GO or rGO as
powder at the air–liquid interface for 42 minutes followed by
42 h post-incubation without the materials (see materials and
methods). Disks of CVD-graphene were topically applied on
RhE surfaces for the same exposure time.
As a preliminary set of experiments, the possible inter-
ference between GBMs and the MTT reduction was investi-
gated. For MTT-interacting test substances, OECD TG 439 con-
siders the execution of the MTT assay on “killed” RhE tissues
after exposure to the test substances, to ensure that the event-
ual MTT conversion, if any, is given only by the substance. As
reported in Fig. 3, none of the GBMs significantly increased
O.D. values as compared to untreated controls (vehicle),
suggesting that in this model, no unspecific interactions with
the MTT reagent can be observed for GBMs. This result was
further corroborated by the absence of a significant O.D.
increase given by incubation of the MTT reagent with RhE
media collected from GBM-treated RhE tissues. As a reference
method that does not show any interference with GBMs,
WST-8 assay was carried out on RhE media collected from
GBM-treated RhE tissues. As expected, also in this case no sig-
nificant O.D. increase was observed (ESI Fig. S8†).
Fig. 3 Interference between GBMs and MTT reagent. According to
OECD TG 439, “killed” RhE tissues were exposed to GBMs for
42 minutes exposure + 42 hours post-incubation without the materials
and the MTT reduction evaluated in comparison with not killed RhE
tissues not exposed to GBMs. Results are presented as optical density
(O.D.) measured at 570 nm and are the mean ± SE of 3 independent
experiments.
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According to the OECD guidelines, irritancy was assessed
by means of tissue viability, measured by the MTT assay. Table 2
shows the results, obtained over 3 independent replicates.
In particular, FLG, GO, rGO and CVD-graphene did not reduce
RhE viability at levels lower than the threshold given by OECD
TG 439 (tissue viability ≤50%) and, therefore, they can be con-
sidered as non-irritant materials. In addition, rGO was able to
significantly reduce RhE viability by 21% (p < 0.05), a level
that, however, does not suggest an irritation potential. In con-
trast, FLG exfoliated with SDS or SDBS significantly reduced
RhE viability by 85% and 65%, respectively, levels higher than
the threshold for irritation potential given by OECD TG 439,
suggesting that these materials can be an irritant for the skin.
The positive control (5% SDS) significantly reduced RhE viabi-
lity by 97% (p < 0.001), indicating that it is an irritant compound.
As an additional control, RhE tissues were exposed also to 5%
SDBS that significantly reduced RhE viability by 98% (p < 0.001).
Considering that some of the FLG materials are obtained by
exfoliation with surfactants, such as SDS, the positive control of
OECD TG 439, a comparison of the eﬀects induced by FLG-SDS
and FLG-SDBS with that induced by FLG was evaluated. RhE
viability reductions induced by FLG-SDS (85%) and FLG-SDBS
(65%) were significantly higher (p values of 0.0005 and 0.0017,
respectively) than that induced by FLG (−1%; Table 3).
Histological analysis
Histological analysis was carried out on hematoxylin/eosin
stained RhE specimens (Fig. 4). Panel A of Fig. 4 shows the
histological analysis of the negative control: the stratum
corneum was characteristically dense and the presence of a
high number of granules was observed in the stratum granulo-
sum. Moreover, nuclei of proliferating keratinocytes of the
stratum spinosum and stratum basale were typically rounded. In
contrast, the positive controls SDS (panel B) and SDBS (panel
C) presented dramatic morphological alterations typical of
skin irritation, with a loss of stratum corneum density as well as
destruction and partial removal of the stratum corneum and
stratum granulosum. In addition, fragmentation of nuclei of
keratinocytes of the stratum spinosum and stratum basale was
observed. For GBMs, loss of the typical density of the stratum
corneum, to a similar extent of that induced by the positive
controls, was observed in RhE exposed to FLG-SDS and
FLG-SDBS (panels E–F). Furthermore, morphological altera-
tions, compatible with skin irritation, were observed in the
stratum corneum and stratum granulosum as well as fragmenta-
tion of nuclei of keratinocytes of the stratum spinosum and
stratum basale. For the other GBMs, no signs of epidermis irri-
tation or other alterations can be observed. Only slight damage
was observed in the outermost layers of the stratum corneum of
GO-treated epidermis (panel G).
In addition, histological analysis demonstrated the pres-
ence of aggregated GBMs (indicated by the arrows; Fig. 4)
above the epidermis surfaces in a diﬀerent fashion depending
on the material: (i) small flat agglomerates for FLG materials,
appearing larger in FLG-SDS and FLG-SDBS; (ii) larger
rounded aggregates for rGO; (iii) absence of material on the
epidermis surface for GO and CVD-graphene. Intriguingly, on
increasing the magnification of the images (Fig. 5), the pres-
ence of small depots of GBMs was observed within the epider-
mis for all the materials, except for CVD-graphene. In all the
cases, these depots were limited to the stratum corneum and
were far smaller than the aggregates observable above the epi-
dermis surfaces.
Cytokine release
A panel of cytokines (IL-1α, IL-6 and IL-8) was evaluated by
specific ELISA assays on RhE media collected after GBM
exposure. Fig. 6 shows the amount of the specific cytokines,
expressed as pg mL−1, released by RhE after GBM treatment,
Table 2 Assessment of skin irritation properties of GBMs using the SkinEthic™ Skin Irritation Test-42bis (OCED TG 439)
Dose % viability (mean ± SE) Viability reduction (%) Irritancy classification
FLG 32 mg cm−2 101 ± 4 −1 NI
FLG-SDS 32 mg cm−2 15 ± 7*** 85 I
FLG-SDBS 32 mg cm−2 35 ± 11*** 65 I
CVD-graphene — 96 ± 1 4 NI
GO 32 mg cm−2 96 ± 2 4 NI
rGO 32 mg cm−2 79 ± 4* 21 NI
Positive control (5% SDS in PBS) 32 μL cm−2 3 ± 1*** 97 I
Positive control (5% SDBS in PBS) 32 μL cm−2 2 ± 1*** 98 I
Results are the mean ± SE of three independent experiments. Irritancy classification was defined on the basis of the threshold given by the
OCED TG 439. Statistical diﬀerences vs. vehicle controls: *, p < 0.05; ***, p < 0.001 (One-way ANOVA and Bonferroni’s post test). NI = non-irritant
substance; I = irritant substance.
Table 3 Comparison between RhE viability reduction (MTT assay)
induced by FLG, FLG-SDS and FLG-SDBS using the SkinEthic™ Skin
Irritation Test-42bis (OCED TG 439)
Dose
Viability
reduction (%) p valuea
Surfactants
contentb
FLG 32 mg cm−2 −1 — 0.8%
FLG-SDS 32 mg cm−2 85 0.0005 36.6%
FLG-SDBS 32 mg cm−2 65 0.0017 38.5%
Results are the mean ± SE of three independent experiments.
a Statistical diﬀerences vs. FLG (One-way ANOVA and Bonferroni’s post
test). b Surfactant content (SDS or SDBS) was evaluated by Elemental
Analysis, considering the % of N and S in the samples.
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Fig. 4 Histological analysis of RhE exposed to vehicle (A), SDS (B) and SDBS (C) positive controls, FLG (D), FLG-SDS (E), FLG-SDBS (F), GO (G), rGO
(H) or CVD (I). After material exposure, RhE specimens were collected, ﬁxed and hematoxylin/eosin stained. Images, representative of 6 diﬀerent
samples, were observed by using an optical microscope. Arrows underline the presence of GBM aggregates and agglomerates above the epidermis
surface. Scale bar: 50 µm.
Fig. 5 Presence of GBMs above the epidermis surface and within the stratum corneum (shown by arrows) in RhE exposed to vehicle (A), SDS (B) and
SDBS (C) positive controls, FLG (D), FLG-SDS (E), FLG-SDBS (F), GO (G), rGO (H) or CVD (I). The image was obtained by an enlargement of Fig. 1.
Scale bar: 20 µm.
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in comparison with negative controls and positive controls
(RhE exposed to 5% SDS or 5% SDBS).
In particular, considering IL-1α (Fig. 6, panel A), as compared
to the negative control (52 pg mL−1), only FLG-SDS and FLG-SDBS
were able to significantly increase its release to 1522 pg mL−1
(increase of 2826%; p < 0.001) and 315 pg mL−1 (increase of
505%; p < 0.01), respectively. In contrast, the other GBMs did not
induce a significant eﬀect with respect to the negative control.
The positive controls SDS and SDBS significantly increased the
release of IL-1α to 1478 pg mL−1 (increase of 2742%; p < 0.001)
and 645 pg mL−1 (increase of 1140%; p < 0.001), respectively.
Regarding IL-6 (Fig. 6, panel B), as compared to the nega-
tive control (8.2 pg mL−1), only FLG-SDS and FLG-SDBS were
able to slightly, but significantly increase its release to 9.0 pg
mL−1 (increase of 10%; p < 0.01) and 8.6 pg mL−1 (increases of
5%; p < 0.05), respectively. In contrast, the other GBMs as well
as the positive controls SDS and SDBS did not induce a signifi-
cant increase of IL-6 as compared to the negative control.
Also considering IL-8 (Fig. 6, panel C), as compared to the
negative control (83 pg mL−1), only FLG-SDS and FLG-SDBS
were able to slightly, but significantly increase its release to
119 pg mL−1 (increase of 43%; p < 0.001) and 104 pg mL−1
(increase of 25%; p < 0.01), respectively. In contrast, the other
GBMs did not induce a significant release with respect to the
negative control. The positive controls SDS and SDBS signifi-
cantly increased the release of IL-8 to 112 pg mL−1 (increase of
35%; p < 0.01) and 178 pg mL−1 (increase of 114%; p < 0.001),
respectively.
Role of surfactants in the irritation potential of FLG-SDS and
FLG-SDBS
To verify the role of surfactant residues in irritation potential
of FLG after exfoliation with SDS or SDBS, after the exfoliation
procedure the supernatants were filtered under vacuum on a
PTFE membrane and washed with Milli-Q water to remove the
excess of each surfactant. Both materials were then physico-
chemically characterized and tested for their skin irritant
potential following OECD TG 439, by histological analysis and
cytokine release (Fig. 7), as reported above.
“Washed” FLG-SDS and FLG-SDBS were characterized by
average lateral dimensions of 500 ± 237 and 495 ± 392 nm,
respectively, as assessed by TEM analysis. Raman spectroscopy
showed flakes constituted by 6 layers for both materials. The
washing procedure significantly reduced the amount of surfac-
tant residue, being equal to 0.22% and 1.90% for FLG-SDS and
FLG-SDBS, respectively, as assessed by elemental analysis
(Fig. 7A). Following OECD TG 439, the so-obtained materials
turned out to be non-irritant, reducing RhE viability at 89% (p
< 0.05) and 90%, respectively. As confirmatory endpoints, also
histological analysis did not show any alteration related to skin
irritation (Fig. 7B), as previously observed for the non-irritant
FLG exfoliated with melamine (Fig. 4, panel D). Histological
analysis also showed the presence of large agglomerates of
FLG-SDS and FLG-SDBS above the epidermis surface, as pre-
viously shown for the same material before the washing step.
In addition, both materials did not induce any significant
release of IL-1α, IL-6 and IL-8 as compared to untreated con-
trols (Fig. 7C), confirming the negligible eﬀects of the washed
materials on RhE.
Discussion
Recently, GBMs have attracted attention for their extraordinary
physicochemical properties, because of a wide range of prom-
ising applications in the biomedical and electronic fields.
Among them, their potential skin applications, mainly as arti-
ficial and electronic skin, wound healing dressings and skin
sensors,3,4 pose a serious concern for the safety of GBMs at the
Fig. 6 Cytokine release from RhE exposed to GBMs. After exposure to
GBMs, RhE media were collected and IL-1α (A), IL-6 (B) and IL-8 (C) were
measured by speciﬁc ELISA assays. The data, reported as pg mL−1 of
cytokines released in the media, are the mean ± SE of three independent
experiments. Statistical diﬀerences vs. negative controls: *, p < 0.05; **,
p < 0.01; ***, p < 0.001 (One-way ANOVA and Bonferroni’s post test).
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cutaneous level. The major risk for human health is actually
related mainly to occupational exposure to these materials.5 In
this scenario, the cutaneous and inhalation exposures rep-
resent the main human routes involved.6 However, as com-
pared to other GBM exposure routes, the cutaneous one is
largely unexplored.7 In this view, we recently provided in vitro
data on the eﬀects of diﬀerent GBMs (FLG and GO) towards
human HaCaT skin keratinocytes. On these cells, GBMs
exerted a significant cytotoxicity11 mediated by ROS-dependent
mitochondrial damage.12 However, despite their wide use,
HaCaT cells are a simplified in vitro model, useful as a first-
round screening, also to investigate the mechanism of skin
toxicity, but unable to completely predict the relevant toxicity
after cutaneous exposure. Indeed, being a proliferating cell
line, HaCaT cells fail to recapitulate in vitro one of the essen-
tial functions of the skin: the barrier function.
Considering the chemical nature of GBMs, in this study we
focused on their potential to cause irritant dermatitis, a poss-
ible outcome consequent to GBM cutaneous exposure. For
decades, the evaluation of skin irritation has been carried out
using the Draize rabbit test for all regulatory studies. Due to
ethical issues, the in vitro EpiSkin™ test method was validated
in 2007 by the European Centre for the Validation of
Alternative Methods (ECVAM) as a full replacement method for
the Draize acute skin irritation test and adopted in OECD TG
439 in 2009. Recently, the SkinEthic™ Reconstructed Human
Epidermis (RhE) model has been formally adopted for the
regulatory assessment of skin irritation (OECD TG 439). The
RhE model is reconstructed starting from normal human skin
keratinocytes grown for 17 days in a chemically defined
medium. The tissue model consists of a fully diﬀerentiated
epidermis including the stratum basale, stratum spinosum,
stratum granulosum and stratum corneum. In this model, a test
method compliant with the OCED TG 439, defined 42bis
(42 minutes exposure + 42 hours post-incubation), was set up
and chosen as the best for its high reproducibility, robustness
and predictive capacity.22 Irritancy prediction is based on the
ability of irritant substances to reduce RhE viability (measured
by the MTT assay) at levels ≤50% as compared to negative
controls.
Since specific OECD guidelines for the prediction of skin
irritation caused by nanomaterials are currently unavailable,
we anyhow chose to follow OECD TG 439, even though it has
been validated only for chemicals. However, some limitations
can be expected for the testing of nanomaterials. For instance,
as for other nanomaterials, GBMs are reported to induce
unspecific interactions with the MTT reagent.9 Hence, as a
first step of the research, we evaluated this possibility. OECD
TG 439 already considers this potential event suggesting, as a
preliminary control check, the evaluation of MTT unspecific
reduction induced by the test substance in “killed” RhE tissue.
In this manner, the “killed” RhE being not viable, the resulting
O.D. signal, if any, can be given only by an unspecific inter-
action between the test substance and the MTT reagent.
However, our results show no unspecific MTT reduction since
the O.D. values recorded in GBM-exposed killed RhE were not
significantly diﬀerent from the negative controls (killed RhE
not exposed to GBMs). This result is probably due to the
barrier property of RhE tissues that do not allow GBMs, added
on the top of the RhE surface, to pass into the compartment
Fig. 7 Irritation potential of “washed” FLG-SDS and FLG-SDBS. Both materials were washed with Milli-Q water after the exfoliation procedure to the
obtained materials characterized by very low amounts of surfactant residues. (A) Physicochemical characterization and skin irritation potential of the
washed materials, assessed by OECD TG 439. (B) Histological analysis of RhE exposed to untreated controls, FLG-SDS or FLG-SDBS after hematoxy-
lin/eosin staining; scale bar: 50 µm. (C) Release of IL-1α, IL-6 and IL-8 from RhE exposed to FLG-SDS or FLG-SDBS as compared to untreated con-
trols, measured by speciﬁc ELISA assays. The data, reported as pg mL−1 of cytokines released in the media, are the mean ± SE of three independent
experiments.
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below the RhE tissue in which culture medium and/or the
MTT reagent are added. To further exclude any interference
between GBMs and the MTT reagent, culture media collected
from the lower compartments after RhE exposure to GBMs
were exposed to the MTT reagent. Also in this case, no increase
of the O.D. values was recorded, strengthening the hypothesis
reported above. On the whole, these results demonstrate the
suitability of the OCED TG 439 to assess GBM irritant poten-
tial, considering the MTT assay as a final readout.
The application of OECD TG 439 demonstrates that among
the tested GBMs (FLG, FLG-SDS, FLG-SDBS, CVD-graphene,
GO and rGO), only FLG exfoliated with SDS and SDBS can be
considered as irritant materials. In fact, the resulting RhE
viabilities (15 and 35%, respectively) were significantly lower
than the threshold given by OECD TG 439 (50% RhE viability).
In contrast, none of the other GBMs were able to reduce RhE
viability under the OECD threshold. Of particular interest is
the eﬀect of FLG-SDS and FLG-SDBS on RhE viability, signifi-
cantly higher than that of FLG. This result may be due to the
higher residues of surfactants in the former materials (36.6
and 38.5%, respectively), used for their exfoliation, as com-
pared to FLG (0.8%). This observation suggests that the irritant
properties of FLG-SDS and FLG-SDBS can be related to the
presence of residual irritant surfactants after the exfoliation
procedure, which are necessary to maintain a stable dispersion
of these GBMs. In contrast, FLG, exfoliated using a barely toxic
agent such as melamine, turned out to be a non-irritant
material, suggesting that the use of non-toxic exfoliation
agents may improve GBM safety.
In line with these observations, histological analysis con-
firmed the absence of signs of irritation for all the GBMs,
except for FLG-SDS and FLG-SDBS. Both FLG-SDS and
FLG-SDBS induced tissue alterations compatible with skin irri-
tation, such as loss of stratum corneum density and disarrange-
ment of the stratum corneum and stratum granulosum as well as
nuclear alterations of keratinocytes of the stratum basale.
Intriguingly, these alterations are similar to those observed in
RhE exposed to the positive controls SDS and SDBS, further
supporting the fact that the tissue changes are exerted by the
surfactant residues in FLG-SDS and FLG-SDBS. Histological
analysis also highlighted the presence of aggregated/agglomer-
ated GBMs (except for GO and CVD-graphene) above the epi-
dermis surface. Also in this case, of particular interest are the
results achieved with FLG materials, showing small flat aggre-
gates/agglomerates for FLG and larger ones for FLG-SDS and
FLG-SDBS. This diﬀerent behavior may be related to the
diﬀerent physicochemical properties of these materials, FLG
being characterized by an average lateral dimension far
smaller than that of FLG-SDS and FLG-SDBS. Intriguingly,
GBM depots (except for CVD-graphene), far smaller than the
aggregates/agglomerates observed above the epidermis
surface, were observed only within the RhE stratum corneum.
This result suggests that highly dispersed not-aggregated/
agglomerated materials could penetrate into the stratum
corneum but could be not able to pass through the stratum
granulosum down to the stratum spinosum and stratum basale.
The stratum corneum being composed of completely kerati-
nized keratinocytes, the absence of toxicity observed for all the
materials, except for FLG-SDS and FLG-SDBS, can be explained
by the inability of these materials to deeply penetrate into the
inner layers of the epidermis and, therefore, that these
materials are unable to directly interact with proliferating kera-
tinocytes of the stratum basale. Once again, this observation
supports the hypothesis that the toxicity observed for FLG-SDS
and FLG-SDBS may be induced by the surfactants rather than
by GBMs themselves. In addition, the inability of GBMs to
reach the stratum basale may explain the apparent discrepancy
between these results and those previously obtained on HaCaT
skin keratinocytes, at least for FLG and GO, that induced sig-
nificant cytotoxicity at high concentrations.11–13 Indeed,
HaCaT cells are a simplified model of proliferating keratino-
cytes more compliant with those typical of the stratum basale.
The conclusions based on the evaluation of RhE viability
and histological analysis are confirmed by the measurement of
IL-1α released by RhE, assessed as a complementary endpoint.
Indeed, in 2007, the ECVAM stated that, even though the accu-
racy of irritant classification is not improved by measuring
IL-1α release, this endpoint may be useful to better classify the
mild to moderate irritancy potential of a test substance.23
Accordingly, irritant treatments, either with SDS or SDBS, sig-
nificantly increase IL-1α release, in line with literature
data.23–27 More importantly, FLG-SDS and FLG-SDBS induced
a significant release of IL-1α, at levels comparable to those
released by the relevant positive controls. This observation
strengthens the conclusion that these materials can be con-
sidered as skin irritants and further supports the hypothesis
that, for these materials, skin irritation may be due to the sur-
factant residues. In contrast, none of the other GBMs provoked
IL-1α release, corroborating the conclusion that they are not
skin irritants. As a further step of the analysis, we focused on
two major pro-inflammatory cytokines significantly involved in
the modulation of skin inflammation: IL-6 and IL-8.28,29 In
line with the results reported above, a slight but significant
release of IL-6 and IL-8 was observed only for FLG-SDS and
FLG-SDBS. Of particular interest is the finding that only these
materials induced a significant IL-6 release, whereas no eﬀect
was exerted by each surfactant alone. This could lead to specu-
lation that the irritation properties of SDS and SDBS residues
in FLG-SDS and FLG-SDBS could increase the pro-inflamma-
tory eﬀect of these two materials, by means of IL-6 and IL-8
release. Furthermore, the significant increase of the pro-
inflammatory IL-6 and of the chemoattractant IL-8 induced by
FLG-SDS and FLG-SDBS cannot exclude a secondary involve-
ment of immune-competent cells, which could further modu-
late skin inflammation. In this view, previous studies on GBMs
showed their ability to upregulate genes implicated in immune
responses as well as to induce the release of pro-inflammatory
cytokines from peripheral blood mononuclear cells.30 In
addition, GO was able to activate the inflammasome in macro-
phages31 and to induce inflammatory cytokine release.32
Hence, to some extent, these results suggest that the tested
GBMs could induce not only an irritant eﬀect, but also an
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inflammatory reaction. Nevertheless, the slight increase of IL-6
and IL-8 (far lower than the induced release of IL-1α) cannot
directly support this hypothesis.
On the whole, using a non-animal model and OECD guide-
line, the results of this study demonstrate that exposure of a
3D reconstructed epidermis to GBMs characterized by very low
residues of irritant surfactants does not induce any signs of
skin irritation. However, it is well known that graphene disper-
sions are not stable in water after the typical exfoliation treat-
ment (sonication and centrifugation).33 Thus, a stabilizing
agent (surfactants among others) is necessary to avoid the pre-
cipitation of the exfoliated graphene. FLG-SDS and FLG-SDBS
used in our study were prepared with an amount of surfactants
suﬃcient to allow a stable GBM dispersion (0.05 mg mL−1).
Indeed, Coleman and co-workers reported that exfoliation with
low concentrations of surfactants (i.e., 0.1 mg mL−1 of SDS or
SDBS) allows stable dispersions of graphene in water at least
for 7 days.34 A subsequent study demonstrated that the lowest
concentration of SDBS allowing the exfoliation and stabilization
of graphene in water was equal to 0.05 mg mL−1.35 Anyway,
since in our model GBMs were topically applied on the RhE
surface as powder, stable water dispersion of these materials
did not represent a limitation. For this reason, to demonstrate
the role of surfactant residues in the irritation potential of
FLG-SDS and FLG-SDBS, as a final step of the study both
materials were further washed after the exfoliation process to
reduce the amount of surfactants (0.22% and 1.90%, respect-
ively). These “washed” materials turned out to be non-irritant as
assessed by OECD TG 439, by histological analysis as well as by
means of cytokine release, as additional endpoints. This result
confirmed the hypothesis that the irritation potential of these
materials is due to the surfactant residues in the final material
rather than to the graphene material itself.
Conclusions
This study was carried out with the aim to investigate the irri-
tation potential of a panel of GBMs using the Reconstructed
human Epidermis, a predictive in vitro 3D model, approved as
an acute non-animal test for skin irritation.
Since no specific guidelines for the testing of nanomaterials
at the skin level are currently available, this study was carried
out on OECD TG 439, even though it has been validated only
for chemicals. As an initial step of the study, we demonstrated
that this guideline could be used also for GBMs, at least con-
sidering the MTT reduction as a final readout. In fact, no inter-
actions between materials and the MTT reagent were found. In
addition, the application of GBMs as powder not only mimics
a normal cutaneous exposure, but also avoids any interference
due to a serum-dependent protein corona formation, com-
monly observed in in vitro experiments, in which GBMs are
suspended in a culture medium containing serum,36 at the
basis of possible underestimation of the in vitro eﬀects.
Considering the threshold given by OECD TG 439, the
tested GBMs can be considered as non-irritant materials if
they contain very low amounts of irritant surfactant residues.
However, being nanomaterials and not chemical compounds
with defined structures, this result should be considered with
care. Indeed, several physicochemical properties (i.e. lateral
dimension, shape, size, agglomeration state, number of layers,
etc.) together with the chemical composition may aﬀect the
irritant response. To be sure that any irritant properties can be
detected, additional analyses were carried out (i.e. histological
analysis and cytokines release) to implement the OECD guide-
line. These analyses corroborated the results obtained evaluat-
ing RhE viability, confirming that GBMs prepared with irritant
surfactants (i.e. FLG-SDS and FLG-SDBS) can be considered as
irritant materials. On the basis of these observations, we
suggest to add these analyses, together with a careful check of
any interference with the MTT assay, whenever a nanomaterial
is tested following this OECD guideline.
On the whole, these results demonstrate that GBMs charac-
terized by very low amounts of irritant surfactant residues do
not seem to induce skin irritation after a single acute exposure.
However, since the presence of surfactants is necessary to
maintain a stable dispersion of GBMs, these results suggest
that the use of non-irritant exfoliation agents (i.e. melamine)
should be preferred for GBMs designed for biological appli-
cations. These results provide a step forward to define GBMs’
occupational safety as well as their safe use in devices directly
applied to the skin, suggesting that the use of non-toxic surfac-
tants as exfoliation agents may improve their safety.
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